Titre :
  • A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.
Auteur : Oettle, H ; Richards, D. ; Ramanathan, R K ; Van Laethem, Jean-Luc ; Peeters, Marc ; Fuchs, M ; Zimmermann, A ; John, W ; Von Hoff, D D ; Arning, M ; Kindler, H L
Informations sur la publication : Annals of oncology, 16, 10, (page 1639-1645)
Statut de publication : Publié, 2005-10
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Gemcitabine
Pancreatic cancer
Pemetrexed
Phase III
Survival
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Deoxycytidine -- administration & dosage -- analogs & derivatives -- therapeutic use
Female
Glutamates -- administration & dosage
Guanine -- administration & dosage -- analogs & derivatives
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasm Metastasis
Neutropenia -- chemically induced
Pancreatic Neoplasms -- drug therapy -- pathology
Survival Analysis
Treatment Outcome
Note : Clinical Trial, Phase III
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdi309
info:pii/mdi309
info:pmid/16087696